Christopher J Kane (Christopher Kane)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Benign Prostatic Hyperplasia

Tyrosine Kinase

Radical Prostatectomy

Prostate Cancer

Top Venues

Prostate cancer and prostatic diseases

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Sriram Deivasigamani, Eric S Adams, Shannon Stock, Srinath Kotamarti, Denis Séguier, Tarek Taha, Lauren E Howard, Alireza Aminsharifi, Ghalib Jibara, Christopher L Amling, William J Aronson, Matthew R Cooperberg, Christopher J Kane, Martha K Terris, Zachary Klaassen, Lourdes Guerrios-Rivera, Stephen J Freedland, Thomas J Polascik
Select black men are potential candidates for prostate hemi-ablation based on radical prostatectomy histopathology for intermediate-risk prostate cancer-a multicenter SEARCH cohort study. Prostate cancer and prostatic diseases (2024)
Mahdi Mottaghi, Lin Gu, Sriram Deivasigamani, Eric S Adams, Joshua Parrish, Christopher L Amling, William J Aronson, Christopher J Kane, Martha K Terris, Lourdes Guerrios-Rivera, Matthew R Cooperberg, Zachary Klaassen, Stephen J Freedland, Thomas J Polascik
Addressing racial disparities in prostate cancer pathology prediction models: external validation and comparison of four models of pathological outcome prediction before radical prostatectomy in the multiethnic SEARCH cohort. Prostate cancer and prostatic diseases (2024)
Sriram Deivasigamani, Eric S Adams, Shannon Stock, Srinath Kotamarti, Denis Séguier, Tarek Taha, Lauren E Howard, Alireza Aminsharifi, Ghalib Jibara, Christopher L Amling, William J Aronson, Matthew R Cooperberg, Christopher J Kane, Martha K Terris, Zachary Klaassen, Lourdes Guerrios-Rivera, Stephen J Freedland, Thomas J Polascik
Select black men are potential candidates for prostate hemi-ablation based on radical prostatectomy histopathology for intermediate-risk prostate cancer-a multicenter SEARCH cohort study. Prostate cancer and prostatic diseases (2024)
Andrei Sergeyev, Lin Gu, Amanda M De Hoedt, Christopher L Amling, William J Aronson, Matthew R Cooperberg, Christopher J Kane, Zachary Klaassen, Martha K Terris, Lourdes Guerrios-Rivera, Stephen J Freedland, Ilona Csizmadi
Diabetes and prostate cancer outcomes in men with nonmetastatic castrate-resistant prostate cancer: Results from the SEARCH Cohort. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)
Zachary Klaassen, Lauren E Howard, Christopher J D Wallis, Jessica L Janes, Amanda M De Hoedt, William J Aronson, Thomas J Polascik, Christopher J Amling, Christopher J Kane, Matthew R Cooperberg, Martha K Terris, Yuan Wu, Stephen J Freedland
Is time to castration resistant prostate cancer a potential intermediate end-point for time to metastasis among men initiating androgen deprivation therapy for non-metastatic prostate cancer with rapid PSA doubling time (<9 months)? Prostate cancer and prostatic diseases (2022)
Michelle S Chen, Lauren E Howard, Shannon Stock, Anna Dolgner, Stephen J Freedland, William Aronson, Martha Terris, Zachary Klaassen, Christopher J Kane, Christopher Amling, Matthew Cooperberg, Timothy John Daskivich
Validation of the prostate cancer comorbidity index in predicting cause-specific mortality in men undergoing radical prostatectomy. Prostate cancer and prostatic diseases (2022)